BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15695689)

  • 1. Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.
    Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):838-42. PubMed ID: 15695689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of PorA during a meningococcal disease epidemic.
    Devoy AF; Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.
    Dyet KH; Martin DR
    Epidemiol Infect; 2006 Apr; 134(2):377-83. PubMed ID: 16490143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003.
    Law DK; Stoltz J; Henderson AM; Tsang RS
    Can J Microbiol; 2005 Jul; 51(7):523-30. PubMed ID: 16175200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characters of epidemic cerebrospinal W135 Neisseria meningitidis strain firstly isolated in Guangdong province].
    Guan DW; Deng XL; Liu MZ; Ke BX; Zhang WL; Liang H; Liang J; Yang XF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):14-8. PubMed ID: 19534873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of porB PCR-amplicon restriction endonuclease analysis as a method to determine porB variable-region sequences in nonserotypeable meningococci.
    Dyet KH; Simmonds RS; Martin DR
    J Clin Microbiol; 2004 Apr; 42(4):1731-3. PubMed ID: 15071034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
    Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
    Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
    Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
    Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
    Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
    J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005.
    Zhang X; Shao Z; Zhu Y; Xu L; Xu X; Mayer LW; Xu J; Jin Q
    Clin Microbiol Infect; 2008 Jun; 14(6):555-61. PubMed ID: 18373693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular typing of meningococci: recommendations for target choice and nomenclature.
    Jolley KA; Brehony C; Maiden MC
    FEMS Microbiol Rev; 2007 Jan; 31(1):89-96. PubMed ID: 17168996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.
    Climent Y; Urwin R; Yero D; Martinez I; Martín A; Sotolongo F; Maiden MC; Pajón R
    Infect Genet Evol; 2010 May; 10(4):546-54. PubMed ID: 20156598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.
    de Filippis I; de Andrade CF; Silva L; Prevots DR; Vicente AC
    Infect Immun; 2007 Jul; 75(7):3683-5. PubMed ID: 17502397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
    Arnold R; Galloway Y; McNicholas A; O'Hallahan J
    Vaccine; 2011 Sep; 29(40):7100-6. PubMed ID: 21803101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
    Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
    J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
    Wong S; Lennon D; Jackson C; Stewart J; Reid S; Crengle S; Tilman S; Aaberge I; O'Hallahan J; Oster P; Mulholland K; Martin D
    Pediatr Infect Dis J; 2007 Apr; 26(4):345-50. PubMed ID: 17414400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine.
    Claus H; Jördens MS; Kriz P; Musilek M; Jarva H; Pawlik MC; Meri S; Vogel U
    Vaccine; 2012 Jan; 30(2):155-60. PubMed ID: 22107847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.
    Holst J; Comanducci M; Bambini S; Muzzi A; Comandi S; Oksnes J; DeTora L; Pizza M; Rappuoli R; Caugant DA
    Vaccine; 2014 May; 32(23):2722-31. PubMed ID: 24631075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.